Bristol-Myers Squibb Co. (NYSE:BMY) on 12/06/2018 declared a dividend of $ 0.4100 per share payable on February 01, 2019 to shareholders of record as of January 04, 2019. Dividend amount recorded is an increase of $ 0.01 from last dividend Paid.

Bristol-Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 3.1520276070% and has increased its dividends for 8 successive years.

Bristol-Myers Squibb Co.'s market cap is $ 84,923,313,970 and has a PE ratio of 0.00. The stock price closed yesterday at $ 52.03 and has a 52 week low/high of $ 46.94 and $ 70.05.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus infection. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Sustiva Franchise; the Reyataz Franchise; and Hepatitis C Franchise.

For more information on Bristol-Myers Squibb Co. click here.